Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 2 | Future Journal of Pharmaceutical Sciences

Fig. 2

From: Octreotide (somatostatin analog) attenuates cardiac ischemia/reperfusion injury via activating nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway in rat model of hyperthyroidism

Fig. 2

Effect of octreotide on infarct size (as present of the total area) in rat hearts exposed to ischemia for 30 min and reperfusion for 120 min. n = 10 rats in each group. Data are represented as mean ± standard deviation. Significance (P < 0.05): *significant when compared with the control group; #significant when compared with HTC groups; $significant when compared with HT+OCT

Back to article page